WallStreetZenWallStreetZen

NASDAQ: CERE
Cerevel Therapeutics Holdings Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

CERE earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$432.8M
Current Profit Margin
0%

CERE Return on Equity

Current Company
-100.1%
Current Industry
-63.5%
Current Market
188%
CERE's Return on Equity (-100.1%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when CERE announces earnings.

CERE Return on Assets

Current Company
-44.5%
Current Industry
2.9%
CERE is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

CERE Return on Capital Employed

Current Company
-36.64%
Current Industry
19.5%
CERE has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CERE vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
CERE$0.00-$416.15M-$432.84MN/AN/A
ASND$286.79M-$442.12M-$517.68M+89.39%N/A
ROIV$123.24M$4.58B$4.47B+41.90%N/A
CYTK$7.53M-$486.05M-$526.24M-24.89%N/A
EXEL$1.83B$312.21M$207.77M+16.47%-22.47%
View Top Biotech Stocks

CERE earnings dates

Next earnings date
May 1, 2024

Cerevel Therapeutics Holdings Earnings & Revenue FAQ

What were CERE's earnings last quarter?

On Invalid Date, Cerevel Therapeutics Holdings (NASDAQ: CERE) reported Q4 2023 earnings per share (EPS) of -$0.76, up 28.81% year over year. Total Cerevel Therapeutics Holdings earnings for the quarter were -$132.66 million. In the same quarter last year, Cerevel Therapeutics Holdings's earnings per share (EPS) was -$0.59.

If you're new to stock investing, here's how to buy Cerevel Therapeutics Holdings stock.

What was CERE's earnings growth in the past year?

As of Q2 2024, Cerevel Therapeutics Holdings's earnings has grown year over year. Cerevel Therapeutics Holdings's earnings in the past year totalled -$432.84 million.

What is CERE's earnings date?

Cerevel Therapeutics Holdings's earnings date is Invalid Date. Add CERE to your watchlist to be reminded of CERE's next earnings announcement.

What was CERE's revenue last quarter?

On Invalid Date, Cerevel Therapeutics Holdings (NASDAQ: CERE) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Cerevel Therapeutics Holdings's revenue was $0.00.

What was CERE's revenue growth in the past year?

As of Q2 2024, Cerevel Therapeutics Holdings's revenue has grown null year over year. Cerevel Therapeutics Holdings's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.